Head Of Early Asset, Obu, International

AstraZeneca

Oncology asset strategy
Phase 2 through registration and launch
International market access
Lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations

Job Summary

  • Lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations.
  • Chair the International Oncology Early Asset forum and lead International input to GPTs; provide science-based recommendations into ILT and support LSPC preparations on wave plans, indication sequencing and launch/no launch propositions.
  • Here your decisions directly shape how cutting-edge oncology medicines reach patients sooner, with real ownership to adapt for local standards of care and payer needs.

Matching Summary

Lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations.

Skills & Requirements

Must-have

  • Oncology asset strategy
  • Phase 2 through registration and launch
  • International market access
  • Cross-functional leadership
  • Companion diagnostics strategy

Nice-to-have

  • Entrepreneurial thinking
  • Adapt for local standards
  • Leveraging big data
  • Learning from colleagues

Key Requirements

  • Advanced scientific qualification (MD, PhD, PharmD)
  • Deep Oncology expertise
  • Senior leadership experience
  • Command of clinical data interpretation
  • Extensive matrix leadership

Work Rights

Not specified

Tailored Resume

Cover Letter